These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 7539862)
1. Practice trends in the diagnosis and management of prostate cancer in the United States. Gee WF; Holtgrewe HL; Albertsen PC; Litwin MS; Manyak MJ; O'Leary MP; Painter MR J Urol; 1995 Jul; 154(1):207-8. PubMed ID: 7539862 [TBL] [Abstract][Full Text] [Related]
2. Differences between urologists in the United States and Canada in the approach to prostate cancer. Fleshner N; Rakovitch E; Klotz L J Urol; 2000 May; 163(5):1461-6. PubMed ID: 10751858 [TBL] [Abstract][Full Text] [Related]
3. [Practice guideline 'Prostate cancer: diagnosis and treatment']. de Reijke TM; Battermann JJ; van Moorselaar RJ; de Jong IJ; Visser AP; Burgers JS Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1771-5. PubMed ID: 18754308 [TBL] [Abstract][Full Text] [Related]
4. Prostate cancer in Victoria in 1993: patterns of reported management. Frydenberg M; Giles GG; Mameghan H; Thursfield VJ; Millar J; Wheelahan JB; Bolton DM; Syme RR Med J Aust; 2000 Mar; 172(6):270-4. PubMed ID: 10860092 [TBL] [Abstract][Full Text] [Related]
5. 1999 American Urological Association Gallup Survey: changes in physician practice patterns, treatment of incontinence and bladder cancer, and impact of managed care. O'Leary MP; Gee WF; Holtgrewe HL; Blute ML; Cooper TP; Miles BJ; Nellans RE; Thomas R; Painter MR; Meyer JJ; Naslund MJ; Gormley EA; Blizzard R; Fenninger RB J Urol; 2000 Oct; 164(4):1311-6. PubMed ID: 10992396 [TBL] [Abstract][Full Text] [Related]
6. Urologists' personal feelings on PSA screening and prostate cancer treatment. Wenzler DL; Rosenberg BH J Eval Clin Pract; 2014 Aug; 20(4):408-10. PubMed ID: 24798149 [TBL] [Abstract][Full Text] [Related]
7. Practice trends in the diagnosis and management of benign prostatic hyperplasia in the United States. Gee WF; Holtgrewe HL; Albertsen PC; Litwin MS; Manyak MJ; O'Leary MP; Painter MR J Urol; 1995 Jul; 154(1):205-6. PubMed ID: 7539861 [TBL] [Abstract][Full Text] [Related]
8. The trend of managing prostate cancer in Taiwan. Wong WY; Chen SC; Chueh SC; Chen J Int J Urol; 2004 Jul; 11(7):510-4. PubMed ID: 15242360 [TBL] [Abstract][Full Text] [Related]
9. What information are urologists extracting from prostate needle biopsy reports and what do they need for clinical management of prostate cancer? Descazeaud A; Rubin MA; Allory Y; Burchardt M; Salomon L; Chopin D; Abbou C; de la Taille A Eur Urol; 2005 Dec; 48(6):911-5. PubMed ID: 16140457 [TBL] [Abstract][Full Text] [Related]
10. The age of the urologist affects the postoperative care of prostate carcinoma patients. Tsai DY; Virgo KS; Colberg JW; Ornstein DK; Johnson ET; Chan D; Johnson FE Cancer; 1999 Oct; 86(7):1314-21. PubMed ID: 10506719 [TBL] [Abstract][Full Text] [Related]
11. Practice patterns in screening and management of prostate cancer in elderly men. Konety BR; Sharp VJ; Verma M; Williams RD; Urology; 2006 Nov; 68(5):1051-6. PubMed ID: 17095076 [TBL] [Abstract][Full Text] [Related]
12. Prostate cancer in older men. Calabrese DA Urol Nurs; 2004 Aug; 24(4):258-64, 268; quiz 269. PubMed ID: 15446376 [TBL] [Abstract][Full Text] [Related]
13. Radical external beam radiotherapy for clinically localized prostate cancer in Japan: differences in the patterns of care between Japan and the United States. Ogawa K; Nakamura K; Onishi H; Sasaki T; Koizumi M; Shioyama Y; Komiyama T; Miyabe Y; Teshima T; Anticancer Res; 2006; 26(1B):575-80. PubMed ID: 16739323 [TBL] [Abstract][Full Text] [Related]
14. Conservative management of prostate cancer in the prostate specific antigen era: the incidence and time course of subsequent therapy. Zietman AL; Thakral H; Wilson L; Schellhammer P J Urol; 2001 Nov; 166(5):1702-6. PubMed ID: 11586206 [TBL] [Abstract][Full Text] [Related]
15. Assessment of American urologists' approach to hormonal management of prostate cancer. Warren KS; Osborn J; Chodak GW Urology; 2006 Dec; 68(6):1305-7. PubMed ID: 17169651 [TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and treatment of bladder and prostate cancer in early stages]. Watanabe H; Nakagawa S; Kojima M Nihon Rinsho; 1996 May; 54(5):1405-9. PubMed ID: 8965375 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of androgen deprivation therapy (ADT) in patients with advanced prostate cancer: association between Gleason score, prostate-specific antigen level, and prior ADT exposure with duration of ADT effect. Ross RW; Xie W; Regan MM; Pomerantz M; Nakabayashi M; Daskivich TJ; Sartor O; Taplin ME; Kantoff PW; Oh WK Cancer; 2008 Mar; 112(6):1247-53. PubMed ID: 18293426 [TBL] [Abstract][Full Text] [Related]
18. [Prognostic factors in patients with prostatic cancer treated with neoadjuvant hormonal therapy and radical prostatectomy]. Villavicencio Mavrich H; Chéchile Toniolo G; Salinas Duffo D; Muñoz Plaza J; Sorraca Ibáñez YJ Arch Esp Urol; 1996 Oct; 49(8):797-806. PubMed ID: 9065276 [TBL] [Abstract][Full Text] [Related]
19. Temporarily deferred therapy (watchful waiting) for men younger than 70 years and with low-risk localized prostate cancer in the prostate-specific antigen era. Carter CA; Donahue T; Sun L; Wu H; McLeod DG; Amling C; Lance R; Foley J; Sexton W; Kusuda L; Chung A; Soderdahl D; Jackmaan S; Moul JW J Clin Oncol; 2003 Nov; 21(21):4001-8. PubMed ID: 14581423 [TBL] [Abstract][Full Text] [Related]
20. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE). Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR; Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]